UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice Journal article
Nie Jiaojiao, Zhou Yongfei, Ding Fan, Liu Xiaoxi, Yao Xin, Xu Lipeng, Chang Yaotian, Li Zeyu, Wang Qingyu, Zhan Li, Zhu Lvzhou, Xie Kunpeng, Li Chenxi, Shi Yuhua, Zhao Qi, Shan Yaming. Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice[J]. International Journal of Biological Macromolecules, 2024, 259(1), 129259.
Authors:  Nie Jiaojiao;  Zhou Yongfei;  Ding Fan;  Liu Xiaoxi;  Yao Xin; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:7.7/7.7 | Submit date:2024/01/25
Influenza a Virus  Self-assembled Ferritin  Multiepitope Nanovaccine  Intranasal Vaccination  Self-adjuvant Activity  Long-lasting Mucosal Immunity  
Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies Journal article
Zheng,Wei, Cai,Dong Bin, Xiang,Ying Qiang, Jiang,Wen Long, Sim,Kang, Ungvari,Gabor S., Huang,Xiong, Huang,Xing Xiao, Ning,Yu Ping, Xiang,Yu Tao. Adjunctive intranasal esketamine for major depressive disorder: A systematic review of randomized double-blind controlled-placebo studies[J]. Journal of Affective Disorders, 2020, 265, 63-70.
Authors:  Zheng,Wei;  Cai,Dong Bin;  Xiang,Ying Qiang;  Jiang,Wen Long;  Sim,Kang; et al.
Favorite | TC[WOS]:61 TC[Scopus]:71  IF:4.9/5.4 | Submit date:2021/03/02
Depression  Intranasal Esketamine  Meta-analysis  Remission  Response  
Effects of Intranasal Cellulose Powder on Asthma Control in Children With Mild-to-Moderate Perennial Allergic Rhinitis: A Randomized, Placebo-Controlled Trial Journal article
Xi Chen, Wei-jie Guan, Shi-xue Sun, Pei-yan Zheng, Li-hong Sun, De-hui Chen, Dan-dan Wang, Chang Chen, Bao-qing Sun, Xiao-hua Douglas Zhang. Effects of Intranasal Cellulose Powder on Asthma Control in Children With Mild-to-Moderate Perennial Allergic Rhinitis: A Randomized, Placebo-Controlled Trial[J]. AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2019, 33(2), 184-193.
Authors:  Xi Chen;  Wei-jie Guan;  Shi-xue Sun;  Pei-yan Zheng;  Li-hong Sun; et al.
Favorite | TC[WOS]:4 TC[Scopus]:5  IF:2.5/2.4 | Submit date:2020/06/12
Intranasal Cellulose Powder  Intranasal Corticosteroids  Asthma  Perennial Allergic Rhinitis  Asthma Control  
Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection Journal article
Xu W., Shen Y., Jiang Z., Wang Y., Chu Y., Xiong S.. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection[J]. Vaccine, 2004, 22(27-28), 3603-3612.
Authors:  Xu W.;  Shen Y.;  Jiang Z.;  Wang Y.;  Chu Y.; et al.
Favorite | TC[WOS]:78 TC[Scopus]:93 | Submit date:2019/01/16
Chitosan-dna  Cvb3  Intranasal  Mucosal Siga  Protection